Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial
An anticancer drug developed by Sichuan Biokin Pharmaceutical took centre stage in a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) Congress in Madrid last week. Researchers said the drug, iza-bren, showed a significant advantage over platinum-based chemotherapy in a phase 3 randomised, double-blind clinical trial conducted at 73 hospitals in China and…
Read original article on News - South China Morning Post →Related news
-
Melaka election tests Malaysia’s fragile unity government as partners clash
Politics
Elections
Malaysia
-
China moves to simplify forex settlements and make cross-border business easier
Economy
Trade
China
-
‘Speak last’: China’s fifth plenum moves to rein in Communist Party leaders
Politics
Government
China
-
Chinese delivery driver divorces American teacher he married 4 months after love confession
Culture & Lifestyle
Relationships
China
-
Is Sara Duterte’s impeachment case being sped up due to Filipinos’ ‘growing impatience’?
Politics
Government
Philippines
-
China’s Communist Party plenum targets passive ‘nice’ guys in anti-corruption push
Politics
Corruption
China
-
North Korea’s low-cost drone push exposes South Korea’s red tape trap
War & Defense
Armed Conflict
North Korea
-
As sales slow, Chinese carmaker courts controversy with overt marketing tactics
Business
Corporate
China